substance p has been researched along with losartan in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chrétien, L; Couture, R; Picard, P | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; Widdop, RE | 1 |
| Eguchi, T; Hatae, T; Kamiya, H; Krause, JE; Nakayama, Y; Okamura, H; Saito, R; Shigeyoshi, Y; Takano, Y | 1 |
| Couture, R; Sgambato, V; Toma, N | 1 |
| Kasparov, S; Paton, JF | 1 |
| Bakker, EN; Spaan, JA; van Der Meulen, ET; VanBavel, E | 1 |
| Arai, T; Fujiwara, H; Kashiki, Y; Takaya, T; Toshima, S; Yasuda, Y; Yoshimii, N | 1 |
| Arai, T; Fujiwara, H; Kashiki, Y; Takaya, T; Toshima, S; Yasuda, Y; Yoshimi, N | 1 |
| Boon, NA; Johnston, NR; Labinjoh, C; Newby, DE; Pellegrini, MP; Webb, DJ | 1 |
| Cicha, MZ; Kopp, UC; Smith, LA | 4 |
| Cicha, MZ; Kopp, UC | 1 |
| Cicha, MZ; Kopp, UC; Yorek, MA | 1 |
3 trial(s) available for substance p and losartan
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Deglutition Disorders; Female; Humans; Hypertension; Imidazoles; Imidazolidines; Losartan; Male; Pneumonia, Aspiration; Stroke; Substance P | 2000 |
Angiotensin II receptor antagonists cannot prevent symptomless dysphagia in hypertensive bedridden older patients with stroke.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Antihypertensive Agents; Bed Rest; Case-Control Studies; Deglutition Disorders; Female; Humans; Hypertension; Losartan; Male; Stroke; Substance P; Treatment Outcome | 2000 |
Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Brachial Artery; Bradykinin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Endothelium, Vascular; Fibrinolysis; Forearm; Humans; Infusions, Intravenous; Isoquinolines; Losartan; Male; Nitroprusside; Plethysmography, Impedance; Quinapril; Substance P; Tetrahydroisoquinolines; Tissue Plasminogen Activator; Vasodilator Agents | 2001 |
12 other study(ies) available for substance p and losartan
| Article | Year |
|---|---|
Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Behavior, Animal; Biphenyl Compounds; Blood Pressure; Drinking; Heart Rate; Imidazoles; Losartan; Male; Neurokinin A; Rats; Rats, Wistar; Receptors, Neurokinin-3; Substance P; Tachykinins; Tetrazoles; Time Factors | 1995 |
Central administration of PD 123319 or EXP-3174 inhibits effects of angiotensin II.
Topics: Angiotensin II; Animals; Brain; Hemodynamics; Imidazoles; Injections, Intraventricular; Losartan; Male; Pyridines; Rats; Rats, Inbred Strains; Substance P; Tetrazoles | 1993 |
Antidiuretic action of tachykinin NK-3 receptor in the rat paraventricular nucleus.
Topics: Angiotensin Receptor Antagonists; Animals; Antidiuretic Hormone Receptor Antagonists; Biphenyl Compounds; Diuresis; Imidazoles; Losartan; Male; Microinjections; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Neurokinin-3; Receptors, Vasopressin; Solubility; Substance P; Tetrazoles; Urine | 1996 |
Effect of angiotensin II on a spinal nociceptive reflex in the rat: receptor and mechanism of action.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Interactions; Hot Temperature; Imidazoles; Injections, Spinal; Losartan; Male; Naloxone; Neurokinin A; Neurokinin B; Nociceptors; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reflex; Spinal Cord; Substance P; Tetrazoles | 1997 |
Differential effects of angiotensin II on cardiorespiratory reflexes mediated by nucleus tractus solitarii - a microinjection study in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bradycardia; Chemoreceptor Cells; Heart Rate; Losartan; Microinjections; Neurokinin-1 Receptor Antagonists; Phrenic Nerve; Piperidines; Pressoreceptors; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reflex; Respiration; Respiratory Physiological Phenomena; Solitary Nucleus; Substance P | 1999 |
Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling.
Topics: Acetylcholine; Albumins; Animals; Antihypertensive Agents; Blood Pressure; Catheterization; Endothelium, Vascular; Fetal Proteins; Free Radical Scavengers; Hot Temperature; Ketanserin; Losartan; Male; Microscopy, Electron; Muscle, Smooth, Vascular; Organ Culture Techniques; Rats; Rats, Wistar; Serotonin; Substance P; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2000 |
Endogenous angiotensin modulates PGE(2)-mediated release of substance P from renal mechanosensory nerve fibers.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Dinoprostone; In Vitro Techniques; Kidney; Losartan; Male; Mechanoreceptors; Nerve Fibers; Neurons, Afferent; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sodium, Dietary; Substance P; Vasoconstrictor Agents | 2002 |
Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dinoprostone; Heart Failure; Kidney; Losartan; Male; Models, Animal; Natriuresis; Neurons, Afferent; Pressure; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sodium; Sodium, Dietary; Substance P | 2003 |
Impaired substance P release from renal sensory nerves in SHR involves a pertussis toxin-sensitive mechanism.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Kidney Pelvis; Losartan; Neurons, Afferent; Osmolar Concentration; Pertussis Toxin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substance P | 2004 |
Activation of endothelin-a receptors contributes to angiotensin-induced suppression of renal sensory nerve activation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Dinoprostone; Dose-Response Relationship, Drug; Drug Combinations; Endothelin A Receptor Antagonists; Kidney; Kidney Pelvis; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Peptides, Cyclic; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium, Dietary; Substance P | 2007 |
Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Baroreflex; Capsaicin; Diabetes Mellitus, Experimental; Dinoprostone; Kidney; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Substance P | 2008 |
Impaired interaction between efferent and afferent renal nerve activity in SHR involves increased activation of alpha2-adrenoceptors.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Dinoprostone; Kidney; Losartan; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha-2; Substance P; Sympathetic Nervous System | 2011 |